Status | Study |
Recruiting |
Study Name: Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes Condition: Acute Biphenotypic Leukemia Acute Erythroid Leukemia Acute Date: 2012-09-19 Interventions: Drug: Cyclophosphamide Given I |
Terminated |
Study Name: Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Date: 2012-05-25 Interventions: Drug: decitabine Given IV |
Active, not recruiting |
Study Name: Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Condition: Adult Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Date: 2012-01-27 Interventions: Drug: Azacitidine Given SC or |
Terminated |
Study Name: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler Condition: Acute Myeloid Leukemia (AML) Acute Promyelocytic Leukemia (APL) Date: 2011-10-28 |
Completed |
Study Name: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies Condition: Acute Lymphoid Leukemia Acute Myeloid Leukemia Date: 2011-10-24 Interventions: Drug: brentuximab vedotin 1.8 |
Recruiting |
Study Name: A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies Condition: Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Date: 2011-06-27 Interventions: Drug: Fludarabine Given IV |
Recruiting |
Study Name: Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome Condition: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Date: 2011-02-15 Interventions: Procedure: Allogeneic Bone Marrow Transplantation |
Completed |
Study Name: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies Condition: Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Date: 2011-01-07 Interventions: Drug: deferasirox Given orally |
Completed |
Study Name: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia in Remission Date: 2010-08-03 Interventions: Procedure: umbilical cord blood transplantation |
Completed |
Study Name: Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome Condition: Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Date: 2010-07-14 Interventions: Other: flow cytometry Correlat |